Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR2227) | ||||||
---|---|---|---|---|---|---|
Drug Name |
R-5495
|
|||||
Synonyms |
D-Ribopyranose; D-Ribopyranoside; D-Ribose; D-Ribose, 99.0%+; R-5495; Ribopyranose; Ribopyranoside; Ribose; SCHEMBL339948; SRBFZHDQGSBBOR-SOOFDHNKSA-N; (3R,4R,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol; (3R,4R,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol; 10257-32-6; C21057; CHEBI:47006; CTK0H1736; D-Rib; DTXSID70450356; EC 700-481-3; Rib; D-ribose
|
|||||
Indication | Congestive heart failure [ICD11: BD10] | Phase 2 | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 150.13 | Topological Polar Surface Area | 90.2 | ||
Heavy Atom Count | 10 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | |||
Cross-matching ID | ||||||
The Predicted Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Predicted Drug Metabolites (PDM) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.